Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomarker Research|December 27, 2016
CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemiaZhiwu Jiang, Di Wu, Shouheng Lin, et al.
Stem Cell Investigation|July 1, 2016
Mechanisms determining the fate of hematopoietic stem cellsShouheng Lin, Ruocong Zhao, Yiren Xiao, et al.
Journal of Hematology & Oncology|May 14, 2017
Current status and perspectives of patient-derived xenograft models in cancer researchYunxin Lai, Xinru Wei, Shouheng Lin, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 9, 2021
Umbilical cord blood CD34+ cells administration improved neurobehavioral status and alleviated brain injury in a mouse model of cerebral palsyYanqun Chang, Shouheng Lin, Yongsheng Li, et al.
Molecular Medicine Reports|November 24, 2023
Cord blood stem cell‑derived Angptl7 ameliorates the severity of bronchopulmonary dysplasia via anti‑inflammatory and proangiogenic effectsZhuxiao Ren, Liling Yang, Jianlan Wang, et al.
Journal of Cellular and Molecular Medicine|October 22, 2019
Efficient gene correction of an aberrant splice site in β-thalassaemia iPSCs by CRISPR/Cas9 and single-strand oligodeoxynucleotidesZeyu Xiong, Yingjun Xie, Yi Yang, et al.
Frontiers in Immunology|April 19, 2021
Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86-Positive B Cell MalignanciesShouheng Lin, Lin Cheng, Wei Ye, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 21, 2023
[SWI/SNF Complex Gene Mutations Promote the Liver Metastasis of Non-small Cell Lung Cancer Cells in NSI Mice]Lingling Gao, Zhi Xie, Shouheng Lin, et al.
Science Immunology|March 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activityYao Li, Jiongliang Wang, Linfu Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 8, 2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53R249S Mutation and is a Potential Therapeutic TargetZhiping Wu, Zhe Wang, Diwei Zheng, et al.
Pageof 2